Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 155Neoplasms 113Carcinoma, Non-Small-Cell Lung 86Prostatic Neoplasms 84Colorectal Neoplasms 84Lung Neoplasms 72Carcinoma, Hepatocellular 51Leukemia, Myeloid, Acute 49Pancreatic Neoplasms 46Neoplasm Metastasis 41Multiple Myeloma 37Recurrence 35Triple Negative Breast Neoplasms 28Melanoma 28Squamous Cell Carcinoma of Head and Neck 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Ovarian Neoplasms 27Head and Neck Neoplasms 27Glioblastoma 27Brain Neoplasms 26Uterine Cervical Neoplasms 25Stomach Neoplasms 24Small Cell Lung Carcinoma 24Rectal Neoplasms 24Endometrial Neoplasms 21Carcinoma, Renal Cell 21Lymphoma, Follicular 20Lymphoma, B-Cell 19Lymphoma 19Motor Activity 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Depressive Disorder, Major × 90 days × Clear all
NCT03833206 2026-04-20

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

BioLite, Inc.

Phase 1/2 Not yet recruiting
12 enrolled

Depressive Disorder, Major

Data powered by HemOnc (CC BY 4.0) Colophon âš¡